Involvement of BCG scar in Kawasaki disease [6]

Indian Pediatrics

Volumn 42, Issue 1, 2005, Pages 83-84

  Antony, Deyis ^a   Jessy, P L ^a  

^a P V S Memorial Hospital Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BCG VACCINE; IMMUNOGLOBULIN;

BLOOD EXAMINATION; CASE REPORT; COUGHING; ERYTHEMA; FEMALE; FEVER; HUMAN; INFANT; INFLAMMATION; IRRITABILITY; LABORATORY TEST; LETTER; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RASH; SCAR; SKIN INDURATION;

BCG VACCINE; CICATRIX; FEMALE; HUMANS; INFANT; INFLAMMATION; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 12744272161     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Tlzard J E. Recognition and management of Kawasaki Disease. Curr Pediatr 1999; 8: 97-101.
2. Brogan PA, Bose A, Burgner O, Shingadla D, et al. Kawasaki Disease: an evidence based approach to diagnosis, treatment and proposals for future research. Arch Dis Child 2002; 88: 288-290.
3. Yokota S. Heat Shock Protein as a predisposing and Immuno-potentiating factor in Kawasaki Disease. Acta Pediatr Jpn.1991; 33: 758-784.
4. Sireci G, Diell F, Salerno A, T cells recognize an Immunodominant epltope of heat shock protein 65 in Kawasaki disease. Mol Med 2000; 8: 581-590.
5. SugawaraT. Immunopathology of skin lesions in Kawasaki Disease. Arerugl 1991; 40: 478-482.